Shows improved locoregional control in locoregionally advanced squamous-cell carcinoma, implying effective treatment enhancement.
Treatment of locoregionally advanced head and neck cancer with concomitant high-dose radiotherapy plus cetuximab improves locoregional control and reduces mortality without increasing the common toxic effects associated with radiotherapy to the head and neck. (ClinicalTrials.gov number, NCT00004227.)
No takes yet. Share an insight, caveat, or question.
Bonner et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: